GSK3 is a regulator of RAR-mediated differentiation

GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells

(2011) J Si et al.   LEUKEMIA

Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML

(2011) Kalpana Gupta et al.   PLoS One

Retinoid pathway and cancer therapeutics

(2010) Nathan Bushue et al.   ADVANCED DRUG DELIVERY REVIEWS

Glycogen synthase kinase−3β inhibitors suppress leukemia cell growth

(2010) Emma Y. Song et al.   EXPERIMENTAL HEMATOLOGY

Glycogen synthase kinase 3: more than a namesake

(2009) Geetha Vani Rayasam et al.   BRITISH JOURNAL OF PHARMACOLOGY

Lithium: Updated Human Knowledge Using an Evidence-Based Approach

(2009) Etienne Marc Grandjean et al.   CNS DRUGS

GSK3 Inhibitors and Disease

(2009) Felix Hernandez et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Identification of 6-Benzylthioinosine as a Myeloid Leukemia Differentiation-Inducing Compound

(2008) D. N. Wald et al.   CANCER RESEARCH

Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3

(2008) Ying Zhou et al.   LEUKEMIA & LYMPHOMA

Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs

(2008) Ana Martinez   MEDICINAL RESEARCH REVIEWS

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy

(2008) Zhong Wang et al.   NATURE

Glycogen Synthase Kinase-3β Inhibition Preserves Hematopoietic Stem Cell Activity and Inhibits Leukemic Cell Growth

(2008) Tiffany Holmes et al.   STEM CELLS